This Week in Psychedelics

A new study reveals insights into how DMT affects the brain; Oregon becomes the first state to grant a production license for psilocybin.

March 24, 2023

This Week...

The results of a new study on DMT's effects on the human brain, as assessed via EEG and fMRI, were released in the Proceedings of the National Academy of Sciences.

The recordings revealed a profound impact across the brain, particularly in areas that are highly evolved in humans and instrumental in planning, language, memory, complex decision-making, and imagination.

Robert Carhart-Harris, one of the study’s authors, said that participants described leaving this world and breaking through into another that was incredibly immersive and richly complex, and sometimes even populated by other beings that they felt might hold a special power over them, like gods.

You can read the results of this study here:

The nominees for a 15-member panel that will oversee Colorado’s new framework for legalized access to psychedelic mushrooms were given initial approval by a Colorado Senate committee.

The Natural Medicine Advisory Board is tasked with helping Colorado’s Department of Regulatory Agencies (DORA) develop rules and regulations to implement the Natural Medicine Health Act, which Colorado voters passed last November.

The measure allows for licensed healing centers to provide access to psilocybin for therapeutic purposes. Check it out:

Oregon regulators approved the nation’s first-ever psilocybin production license under a novel state-based regulatory framework for broad access to the psychedelic that voters approved in 2020.

The Oregon Health Authority (OHA) announced on Wednesday that it granted a psilocybin manufacturer license to Satori Farms PDX LLC. Here’s more:

Did You Know?

Did you know that there is now a psychedelics political action committee (PAC)?

It’s unlikely Terrence McKenna ever imagined such a thing while writing “Food of the Gods,” but it exists.

It’s actually called the Psychedelic Medicine Political Action Committee, and its goal is to encourage policymakers on both sides of the aisle to revise long-standing restrictions on psychedelics in light of growing evidence of their therapeutic benefits.

The PAC is now seeking to raise $10 million this year to further its efforts. Here’s more: